"[320A09BE81D3]" . . "302122" . . "RIV/61989592:15310/10:10212659!RIV11-GA0-15310___" . "15310" . . . "Dole\u017Eal, Karel" . . "290968" . . . "Strnad, Miroslav" . "The present invention relates to certain 6-(2-aminobenzylamino)purines, represented by the general formula I, which can be used in CDK inhibition, in particular, in the treatment of viral infections and diseases involving cell proliferation. The invention further includes pharmaceutical compositions containing the aforementioned compounds."@en . . "Praha" . "Substituovan\u00E9 deriv\u00E1ty 6-(2-aminobenzylamino)purinu, jejich pou\u017Eit\u00ED jako l\u00E9\u010Diva a p\u0159\u00EDpravky tyto slou\u010Deniny obsahuj\u00EDc\u00ED"@cs . . "Substituted derivatives of 6-(2-aminobenzylamino)purine"@en . . "UPV\u010CR" . . "Abstrakt: \u0158e\u0161en\u00ED se t\u00FDk\u00E1 konkr\u00E9tn\u00EDch 6-(2-aminobenzylamino)purin\u016F se spole\u010Dn\u00FDm obecn\u00FDm vzorcem I, kter\u00E9 se pou\u017E\u00EDvaj\u00ED pro inhibici CDK, zejm\u00E9na p\u0159i o\u0161et\u0159ov\u00E1n\u00ED virov\u00FDch infekc\u00ED a onemocn\u011Bn\u00ED, kter\u00E1 zahrnuj\u00ED bun\u011B\u010Dnou proliferaci, jako jsou n\u00E1dory, psori\u00E1za, resten\u00F3za, revmatick\u00E1 artritida, atd., a farmaceutick\u00FDch p\u0159\u00EDpravk\u016F tyto slou\u010Deniny obsahuj\u00EDc\u00ED." . "P(GA204/08/0511), P(GA301/08/1649), P(KAN200380801)" . "Substituovan\u00E9 deriv\u00E1ty 6-(2-aminobenzylamino)purinu, jejich pou\u017Eit\u00ED jako l\u00E9\u010Diva a p\u0159\u00EDpravky tyto slou\u010Deniny obsahuj\u00EDc\u00ED" . . "VOJT\u011A\u0160EK, Bo\u0159ivoj" . . . "Univerzita Palack\u00E9ho v Olomouci, BioApex s.r.o." . . . . "Kry\u0161tof, Vladim\u00EDr" . . . . . . "RIV/61989592:15310/10:10212659" . . "Substituovan\u00E9 deriv\u00E1ty 6-(2-aminobenzylamino)purinu, jejich pou\u017Eit\u00ED jako l\u00E9\u010Diva a p\u0159\u00EDpravky tyto slou\u010Deniny obsahuj\u00EDc\u00ED" . "HAVL\u00CD\u010CEK, Libor" . "Abstrakt: \u0158e\u0161en\u00ED se t\u00FDk\u00E1 konkr\u00E9tn\u00EDch 6-(2-aminobenzylamino)purin\u016F se spole\u010Dn\u00FDm obecn\u00FDm vzorcem I, kter\u00E9 se pou\u017E\u00EDvaj\u00ED pro inhibici CDK, zejm\u00E9na p\u0159i o\u0161et\u0159ov\u00E1n\u00ED virov\u00FDch infekc\u00ED a onemocn\u011Bn\u00ED, kter\u00E1 zahrnuj\u00ED bun\u011B\u010Dnou proliferaci, jako jsou n\u00E1dory, psori\u00E1za, resten\u00F3za, revmatick\u00E1 artritida, atd., a farmaceutick\u00FDch p\u0159\u00EDpravk\u016F tyto slou\u010Deniny obsahuj\u00EDc\u00ED."@cs . . . "Zatloukal, Marek" . . "Substituted derivatives of 6-(2-aminobenzylamino)purine"@en . "6"^^ . "6-(2-aminobenzylamino)purine derivatives, psoriasis, restenosis"@en . . "2010-09-13+02:00"^^ . "6"^^ . "Substituovan\u00E9 deriv\u00E1ty 6-(2-aminobenzylamino)purinu, jejich pou\u017Eit\u00ED jako l\u00E9\u010Diva a p\u0159\u00EDpravky tyto slou\u010Deniny obsahuj\u00EDc\u00ED"@cs . .